BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28323122)

  • 21. [Hepatocellular carcinoma in an inflammatory adenoma with β-catenin mutation in a patient with hepatocellular adenomatosis due to germline mutation in HNF1α].
    Ridder DA; Duret D; Wörns MA; Schotten S; Heinrich S; Kloth M; Springer E; Roth W; Straub BK
    Z Gastroenterol; 2019 Jan; 57(1):46-51. PubMed ID: 30641602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation Detection of Fibroblast Growth Factor Receptor 3 for Infiltrative Hepatocellular Carcinoma by Whole-Exome Sequencing.
    Yan X; Shao C; Chen C; Chen J; Gu S; Huang L; Fu X; Zhao H; Qiu Y
    Dig Dis Sci; 2017 Feb; 62(2):407-417. PubMed ID: 28058595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole genome sequencing of matched tumor, adjacent non-tumor tissues and corresponding normal blood samples of hepatocellular carcinoma patients revealed dynamic changes of the mutations profiles during hepatocarcinogenesis.
    Mao R; Liu J; Liu G; Jin S; Xue Q; Ma L; Fu Y; Zhao N; Xing J; Li L; Qiu Y; Lin B
    Oncotarget; 2017 Apr; 8(16):26185-26199. PubMed ID: 28412734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic structures of dysplastic nodule and concurrent hepatocellular carcinoma.
    Lee M; Kim K; Kim SY; Jung SH; Yoon J; Kim MS; Park HC; Jung ES; Chung YJ; Lee SH
    Hum Pathol; 2018 Nov; 81():37-46. PubMed ID: 29949741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The genomic landscape of hepatoblastoma and their progenies with HCC-like features.
    Eichenmüller M; Trippel F; Kreuder M; Beck A; Schwarzmayr T; Häberle B; Cairo S; Leuschner I; von Schweinitz D; Strom TM; Kappler R
    J Hepatol; 2014 Dec; 61(6):1312-20. PubMed ID: 25135868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole genome sequencing discriminates hepatocellular carcinoma with intrahepatic metastasis from multi-centric tumors.
    Furuta M; Ueno M; Fujimoto A; Hayami S; Yasukawa S; Kojima F; Arihiro K; Kawakami Y; Wardell CP; Shiraishi Y; Tanaka H; Nakano K; Maejima K; Sasaki-Oku A; Tokunaga N; Boroevich KA; Abe T; Aikata H; Ohdan H; Gotoh K; Kubo M; Tsunoda T; Miyano S; Chayama K; Yamaue H; Nakagawa H
    J Hepatol; 2017 Feb; 66(2):363-373. PubMed ID: 27742377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profiling of exome mutations associated with progression of HBV-related hepatocellular carcinoma.
    Woo HG; Kim SS; Cho H; Kwon SM; Cho HJ; Ahn SJ; Park ES; Lee JS; Cho SW; Cheong JY
    PLoS One; 2014; 9(12):e115152. PubMed ID: 25521761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiregional whole-genome sequencing of hepatocellular carcinoma with nodule-in-nodule appearance reveals stepwise cancer evolution.
    Takeda H; Takai A; Kumagai K; Iguchi E; Arasawa S; Eso Y; Shimizu T; Ueda Y; Taura K; Uemoto S; Kita R; Haga H; Marusawa H; Fujimoto A; Seno H
    J Pathol; 2020 Dec; 252(4):398-410. PubMed ID: 32815153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological features.
    Haefliger S; Hench J; O'Rourke CJ; Meyer-Schaller N; Uzun S; Saldarriaga J; Weber A; Mazzucchelli L; Jermann P; Frank S; Andersen JB; Terracciano L; Sempoux C; Matter MS
    Histopathology; 2023 Apr; 82(5):722-730. PubMed ID: 36583256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma.
    Xu LX; He MH; Dai ZH; Yu J; Wang JG; Li XC; Jiang BB; Ke ZF; Su TH; Peng ZW; Guo Y; Chen ZB; Chen SL; Peng S; Kuang M
    Ann Oncol; 2019 Jun; 30(6):990-997. PubMed ID: 30916311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated exome sequencing and microarray analyses detected genetic defects and underlying pathways of hepatocellular carcinoma.
    Chong ML; Knight J; Peng G; Ji W; Chai H; Lu Y; Wu S; Li P; Hu Q
    Cancer Genet; 2023 Aug; 276-277():30-35. PubMed ID: 37418972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype-phenotype correlation of CTNNB1 mutations reveals different ß-catenin activity associated with liver tumor progression.
    Rebouissou S; Franconi A; Calderaro J; Letouzé E; Imbeaud S; Pilati C; Nault JC; Couchy G; Laurent A; Balabaud C; Bioulac-Sage P; Zucman-Rossi J
    Hepatology; 2016 Dec; 64(6):2047-2061. PubMed ID: 27177928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
    Calderaro J; Couchy G; Imbeaud S; Amaddeo G; Letouzé E; Blanc JF; Laurent C; Hajji Y; Azoulay D; Bioulac-Sage P; Nault JC; Zucman-Rossi J
    J Hepatol; 2017 Oct; 67(4):727-738. PubMed ID: 28532995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accumulation of Deleterious Passenger Mutations Is Associated with the Progression of Hepatocellular Carcinoma.
    Budzinska MA; Tu T; d'Avigdor WM; McCaughan GW; Luciani F; Shackel NA
    PLoS One; 2016; 11(9):e0162586. PubMed ID: 27631787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exome Sequencing of Fresh-frozen or Formalin-fixed Paraffin-embedded B6C3F1/N Mouse Hepatocellular Carcinomas Arising Either Spontaneously or due to Chronic Chemical Exposure.
    Auerbach SS; Xu M; Merrick BA; Hoenerhoff MJ; Phadke D; Taxman DJ; Shah R; Hong HL; Ton TV; Kovi RC; Sills RC; Pandiri AR
    Toxicol Pathol; 2018 Aug; 46(6):706-718. PubMed ID: 30045675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing trends in malignant transformation of hepatocellular adenoma.
    Farges O; Ferreira N; Dokmak S; Belghiti J; Bedossa P; Paradis V
    Gut; 2011 Jan; 60(1):85-9. PubMed ID: 21148580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A genomic case study of mixed fibrolamellar hepatocellular carcinoma.
    Griffith OL; Griffith M; Krysiak K; Magrini V; Ramu A; Skidmore ZL; Kunisaki J; Austin R; McGrath S; Zhang J; Demeter R; Graves T; Eldred JM; Walker J; Larson DE; Maher CA; Lin Y; Chapman W; Mahadevan A; Miksad R; Nasser I; Hanto DW; Mardis ER
    Ann Oncol; 2016 Jun; 27(6):1148-1154. PubMed ID: 27029710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA.
    Hechtman JF; Abou-Alfa GK; Stadler ZK; Mandelker DL; Roehrl MHA; Zehir A; Vakiani E; Middha S; Klimstra DS; Shia J
    Hum Pathol; 2019 Jan; 83():1-6. PubMed ID: 30121369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
    Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J
    Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular Carcinoma Arising in an HNF-1α-Mutated Adenoma in a 23-Year-Old Woman with Maturity-Onset Diabetes of the Young: A Case Report.
    Stueck AE; Qu Z; Huang MA; Campreciós G; Ferrell LD; Thung SN
    Semin Liver Dis; 2015 Nov; 35(4):444-9. PubMed ID: 26676820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.